News Outlets Discuss Various Efforts To Develop, Test Ebola Vaccines

News outlets report on various efforts to develop and test Ebola vaccines.

Associated Press: Johnson & Johnson plans Ebola vaccine testing (10/22).
CQ HealthBeat: J&J Plans More Than 1 Million Ebola Vaccine Doses Next Year (Young, 10/22).
Financial Times: GSK expects first doses of Ebola vaccine ready by year end (Ward, 10/22).
The Hill: NIH launches trial of second Ebola vaccine (Viebeck, 10/22).
Reuters: Drugmakers may need indemnity for fast-tracked Ebola vaccines (Hirschler/Nebehay, 10/23).
Reuters: E.U. earmarks $250 million to help develop Ebola vaccines: sources (Hirschler, 10/22).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.